PET criteria for diagnosis of Alzheimer’s disease and other dementias

[1]  H. Karbe,et al.  Comparison between cerebral glucose metabolism and late evoked potentials in patients with Alzheimer’s disease , 1989 .

[2]  W. Heiss,et al.  [Contribution of positron emission tomography to the diagnosis of dementia]. , 2008, Deutsche medizinische Wochenschrift.

[3]  K. Herholz,et al.  Effect of Piracetam on Cerebral Glucose Metabolism in Alzheimer's Disease as Measured by Positron Emission Tomography , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  M. Hayden,et al.  The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease , 1987, Neurology.

[5]  J. Mazziotta,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. , 1987, Archives of general psychiatry.

[6]  R Harrop,et al.  Positron emission tomography and histopathology in Pick's disease , 1987, Neurology.

[7]  J. Mazziotta,et al.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. , 1987, The New England journal of medicine.

[8]  A. Karenberg,et al.  Störungen des Glukosestoffwechsels bei Pickscher Erkrankung , 1986 .

[9]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[10]  W. Heiss,et al.  Zerebraler Glukosestoffwechsel bei präseniler Demenz vom Alzheimer-Typ - Verlaufskontrolle unter Therapie mit muskarinergem Cholinagonisten - , 1986 .

[11]  K Wienhard,et al.  PET, CT, and MR Imaging in Cerebrovascular Disease , 1986, Journal of computer assisted tomography.

[12]  A. Kurz,et al.  [Cholinergic treatment strategies in Alzheimer's disease]. , 1986, Der Nervenarzt.

[13]  J. Haxby,et al.  Positron emission tomography in Alzheimer's disease , 1986, Neurology.

[14]  R. Frackowiak,et al.  Regional cerebral blood flow and oxygen metabolism in dementia due to vascular disease. , 1986, Gerontology.

[15]  K. Davis,et al.  Cholinergic approaches to the treatment of Alzheimer's disease. , 1986, British medical bulletin.

[16]  A. Lang,et al.  Striatal dopamine distribution in Parkinsonian patients during life , 1985, Journal of the Neurological Sciences.

[17]  C. Markham,et al.  Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia , 1985 .

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[19]  K. Herholz,et al.  Regional Kinetic Constants and Cerebral Metabolic Rate for Glucose in Normal Human Volunteers Determined by Dynamic Positron Emission Tomography of [18F]-2-Fluoro-2-Deoxy-D-Glucose , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  C. Markham,et al.  Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease , 1984, Annals of neurology.

[21]  R. Morgan,et al.  Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease. , 1984, Psychopharmacology bulletin.

[22]  B. Reisberg,et al.  Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  N. Foster,et al.  Alzheimer's disease , 1983, Neurology.

[24]  R H Huesman,et al.  Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.

[25]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[26]  J C Mazziotta,et al.  Tomographic mapping of human cerebral metabolism: Sensory deprivation , 1982, Annals of neurology.

[27]  L. Iversen,et al.  Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. , 1982, Experimental brain research.

[28]  R. S. J. Frackowiak,et al.  REGIONAL CEREBRAL OXYGEN SUPPLY AND UTILIZATION IN DEMENTIAA CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN-15 AND POSITRON TOMOGRAPHY A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN - 15 AND POSITRON TOMOHRAPHY , 1981 .

[29]  T Jones,et al.  Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. , 1981, Brain : a journal of neurology.

[30]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[31]  K. Davis,et al.  Physostigmine: improvement of long-term memory processes in normal humans. , 1978, Science.

[32]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[33]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.